• No results found

Ten years of biosimilars in Europe: development and evolution of the regulatory pathways

N/A
N/A
Protected

Academic year: 2020

Share "Ten years of biosimilars in Europe: development and evolution of the regulatory pathways"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 Overview of eMA guidelines related to the development and approval of biosimilars.Abbreviations: eMA, european Medicines Agency; GCSF, granulocyte colony-stimulating factor; GH, growth hormone; iFNα, interferon alpha; iFNβ, interferon beta.
Table 1 examples of analytical methods for characterizing molecular attributes of a biologic

References

Related documents

To create and assign device models, refer to the procedures for the signal model command in the Allegro PCB and Package Physical Layout Command Reference.

Standardization of herbal raw drugs include passport data of raw plant drugs, botanical authentification, microscopic & molecular examination, identification of

Surgical Site Infection Reduction Through Nasal Decolonization Prior to Surgery..

Abstract: This report discusses recent developments of psychotraumatology mainly related to the recently published ICD-11, but also from a societal point of view.The selected aspects

The proposed Peyton Slough Hydraulic Relief Project consists of removing an existing hydraulic restriction in Peyton Slough to improve water exchange between McNabney Marsh and Suisun

Results obtained in the present study revealed mild alterations in the kidney function, reflected as a significant increase in urea of KT/WR-treated rats and a significant decrease

повышается также скорость входа протонов в матрикс (рис.. Влияние МрТр на трансмембранный обмен ионов в митохондриях. Открывание МРТР, как уже было показано нами